Quest Diagnostics elects Timothy Wentworth to board of directors

Jim Davis, chairman, CEO and president of Quest Diagnostics
Jim Davis, chairman, CEO and president of Quest Diagnostics - Quest Diagnostics
0Comments

Quest Diagnostics Incorporated announced on Mar. 13 that Timothy Wentworth has been elected to its board of directors, bringing the total number of board members to eleven.

The appointment is significant as Quest Diagnostics continues to expand its leadership team with experienced executives from the healthcare industry. Wentworth’s background includes leading several major healthcare organizations and working across multiple sectors relevant to Quest’s operations.

Jim Davis, chairman, CEO and president of Quest Diagnostics, said, “As a former CEO of several large, publicly traded healthcare organizations, Tim brings incredible leadership experience to the Quest board. His depth in the many channels Quest serves, including health plan, employer and consumer, combined with his real-world operations and HR expertise, makes him an exceptional addition to the Quest team as we work together to create a healthier world, one life at a time.”

Wentworth most recently served as chief executive officer of Walgreens Boots Alliance where he oversaw restructuring efforts ahead of its sale in mid-2025. He was also founding CEO of Evernorth Health Services under The Cigna Group and previously led Express Scripts after its acquisition of Medco Health Solutions. During his tenure at Express Scripts following the Medco transaction, the company became a Fortune 25 business with revenues exceeding $100 billion before being acquired by Cigna in 2018. His earlier career included senior roles at Mary Kay and PepsiCo.

Timothy M. Ring, lead independent director at Quest Diagnostics, said: “Tim is an accomplished business leader who knows how to run highly complex, industry-leading healthcare companies to generate growth and value at scale. We are fortunate to welcome him to our board.”

Wentworth currently serves on the boards of Walgreens Holding Company and Dfinitiv and has held previous directorships with Walgreens Boots Alliance, Accredo Health Group, Express Scripts, and Forge Health. He holds degrees from Cornell University and Monroe Community College.



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Michele Siekerka President & CEO

EPA delays PFAS reporting rule submission date for businesses to 2027

The Environmental Protection Agency has postponed key PFAS product reporting requirements until at least January 31, 2027. Businesses now have additional time before compliance deadlines take effect under revised federal rules.

Michele Siekerka President & CEO

New Jersey sees $2.8 billion net outflow in adjusted gross income for 2022-2023

New IRS data shows nearly $2.8 billion left NJ in taxable income during tax year 2022-2023—an improvement over last year’s record outflow but still raising concerns among business leaders about long-term impacts on economic health.

Michele Siekerka President & CEO

NJ Reentry Corporation conference focuses on trauma-informed mental health in justice reform

The New Jersey Reentry Corporation hosted a conference focusing on trauma-informed approaches for those leaving incarceration or addiction treatment. Leaders discussed integrating mental health care into justice reform efforts. The event highlighted calls for more clinically driven responses within reentry policies.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from North Jersey Business Daily.